Effect of hyperglycemia treatment on complications rate after pediatric cardiac surgery

Bahman Naghipour1, Mahdieh Bagerpour2, Kamran Shadvar1

  • 1Department of Anesthesiology and Intensive Care, Medical Faculty, Tabriz University of Medical Sciences, Tabriz, Iran.

Insights

Controlling blood sugar during pediatric cardiac surgery reduces complications. Accurate glucose management with insulin infusion shortened hospitalization and extubation times in children undergoing cardiopulmonary bypass.

Area of Science:

  • Pediatric Cardiac Surgery
  • Anesthesiology
  • Endocrinology

Background:

  • Intraoperative hyperglycemia is a concern in pediatric cardiac surgery.
  • Elevated blood glucose levels can lead to adverse outcomes.
  • Effective blood sugar control strategies are needed.

Purpose of the Study:

  • To investigate the complications of intraoperative hyperglycemia in children undergoing cardiac surgery.
  • To evaluate the benefits of insulin administration for precise blood glucose management.

Main Methods:

  • Randomized clinical trial involving 50 children under 12 undergoing cardiac surgery with cardiopulmonary bypass.
  • Intraoperative intravenous insulin infusion targeting blood glucose of 110-140 mg/dL.
  • Regular monitoring of blood glucose and arterial blood gas (ABG) every 30 minutes.

Main Results:

  • The insulin group required less inotrope use compared to the placebo group.
  • Hospitalization and extubation times were significantly shorter in the insulin group (P=0.03 and P=0.005, respectively).
  • No significant difference in ICU hospitalization duration between groups.

Conclusions:

  • Intraoperative hyperglycemia is linked to prolonged intubation and hospitalization.
  • Accurate blood glucose control using insulin infusion positively impacts outcomes.
  • This strategy helps reduce complications and shorten hospital stays in pediatric cardiac surgery patients.

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
723
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
356
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
417
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
277
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.3K